The paper covers low- and high-grade gliomas, craniopharyngiomas, pituitary adenomas, germ cell tumors, Langerhans cell histiocytosis and pineal parenchymal tumors, all of which can arise in this ...
Mirdametinib is a small molecule commercialized by SpringWorks Therapeutics, with a leading Pre-Registration program in Neurofibromatoses Type I (Von Recklinghausen's Disease).